日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Clinical characteristics and APOE variant spectrum in Chinese patients with lipoprotein glomerulopathy

中国脂蛋白肾小球病患者的临床特征和APOE变异谱

Li, Mengshi; Li, Yang; Jiang, Lei; Wang, Xin; Liu, Zhiying; Song, Zhuoran; You, Ruilian; Chen, Yuqing; Zhou, Xujie; Zhang, Hong

XBP1s Mediates Cross-resistance to Combination Treatment of CDK4/6 Inhibitors plus Endocrine Therapy in Breast Cancer.

XBP1s介导乳腺癌中CDK4/6抑制剂联合内分泌治疗的交叉耐药性。

Sang Yuting, Liu Shiyang, Zhou Xujie, Chi Weiru, Xiong Min, Chen Ming, Ren Hengyu, Liu Douwaner, Zhang Liyi, Xue Jingyan, Chi Yayun, Wu Jiong

LINC01235 Promotes Clonal Evolution through DNA Replication Licensing-Induced Chromosomal Instability in Breast Cancer.

LINC01235 通过 DNA 复制许可诱导的染色体不稳定性促进乳腺癌的克隆进化

Zhang Qi, Wang Xuliren, Shao Zhibo, Zhang Yi, Zhang Liyi, Chen Ming, Zhou Xujie, Zhu Han, Zhou Yue, Lu Xinya, Li Pei, Chi Weiru, Li Lun, Shao Zhi-Ming, Huang Shenglin, Xue Jingyan, Chi Yayun, Wu Jiong, Xiu Bingqiu

Non-α-biased IL-2 enhances both intratumoral and subcutaneous CpG/α-OX40 therapy, unleashing systemic antitumor immunity in mice

非α偏向性IL-2可增强瘤内和皮下CpG/α-OX40疗法,从而在小鼠体内激活全身抗肿瘤免疫。

Huang, Kejie; Ding, Xiaobo; Wen, Xuehuan; Huang, Chaoming; Chen, Yan; Zhou, Xujie; Zhou, Leying; He, Yi; Bai, Zhixiang; Zhang, Chunhong; Jin, Yi; Li, Jianmin; Fei, Zhenghua; Li, Wenfeng; Chen, Chen

Lactobacillus casei Cell Wall Extract and Production of Galactose-Deficient IgA1 in a Humanized IGHA1 Mouse Model

干酪乳杆菌细胞壁提取物及在人源化IGHA1小鼠模型中产生半乳糖缺陷型IgA1

Li, Run; Wang, Manliu; Li, Jingyi; Zhu, Li; Xie, Xinfang; Wang, Hui; Zhang, Xu; Tian, Wenmin; Zhang, Yong; Dong, Yaping; Zan, Jincan; Li, Hongyu; Zhang, Yuemiao; Zhou, Xujie; Shi, Sufang; Shu, Chutian; Liu, Lijun; Jin, Jing; Lv, Jicheng; Zhang, Hong

Long-term evaluation of the timing of corticosteroid therapy in an IgA nephropathy cohort

对IgA肾病患者群体中皮质类固醇治疗时机的长期评估

Hou, Wanyin; Yang, Haiyan; Chen, Pei; Tang, Chen; Zhou, Xujie; Liu, Lijun; Zhu, Li; Shi, Sufang; Lv, Jicheng; Zhang, Hong

Novel therapies improve prognosis of IgAN and limit the applicability of the International IgA Nephropathy Prediction Tool

新型疗法改善了IgA肾病的预后,并限制了国际IgA肾病预测工具的适用性。

Shen, Xue; Chen, Pei; Liu, Lijun; Shi, Sufang; Zhou, Xujie; Barbour, Sean J; Lv, Jicheng; Zhang, Hong

Age at disease onset and risk of chronic kidney disease in patients with heterozygous disease-causing variants in COL4A3 and COL4A4

携带 COL4A3 和 COL4A4 杂合致病变异的患者发病年龄与慢性肾脏病风险的关系

Hu, Ningning; Sun, Lei; Dai, Xuantong; Zhao, Ziyi; Zhang, Xi; Rao, Jia; Zhou, Xujie; Fang, Yi; Shi, Yiqin; Jin, Shi; Xu, Xialian; Yu, Jiawei; Bian, Qi; Fan, Ying; Chen, Jia; Yang, Ning; Lin, Lirong; Peng, Zhangzhe; Liu, Guangyi; Zheng, Bixia; Sun, Yu; Zhao, Mingzhu; Sun, Xin; Xu, Hong; Huang, Wenyan; Jiang, Gengru; Lin, Fujun

Effects of Podocyte Foot Process Effacement on Kidney Prognosis and Response to Immunosuppressive Therapy in IgA Nephropathy

足细胞足突消失对IgA肾病肾脏预后及免疫抑制治疗反应的影响

Guo, Yingman; Ren, Yali; Shi, Sufang; Wang, Suxia; Zhou, Xujie; Liu, Lijun; Lv, Jicheng; Zhu, Li; Zhang, Hong

Association Between Relapse and Long-Term Kidney Outcomes in IgA Nephropathy

IgA肾病复发与长期肾脏预后之间的关联

Shen, Xue; Chen, Pei; Hui, Miao; Li, Jingyi; Hou, Wanyin; Yang, Hongyu; Li, Yang; Liu, Lijun; Shi, Sufang; Zhou, Xujie; Lv, Jicheng; Zhang, Hong